Skip to main content
Fig. 5 | Diabetology & Metabolic Syndrome

Fig. 5

From: Therapeutic effects on the development of heart failure with preserved ejection fraction by the sodium-glucose cotransporter 2 inhibitor dapagliflozin in type 2 diabetes

Fig. 5

The effects of dapagliflozin on apoptosis and DNA fragmentation in cardiomyocytes. a Representative images of TUNEL staining. Bar = 200 μm, magnification = ×10. b Quantification of TUNEL-positive nuclei. c Representative western blot bands of cleaved PARP-1 and Bcl-2 levels in the myocardium. d, e Relative protein levels were densitometrically quantified with ImageJ. Data are expressed as the mean ± SD. *P < 0.05, **P < 0.01 vs. Lean; #P < 0.05, ##P < 0.01 vs. ZDF

Back to article page